DOCSLIB.ORG

Cardiovascular Device Infections

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cardiovascular Device Infections The Cyprus CARDIOVASCULAR DEVICE INFECTIONS PROGRAM 10.9.2019 Crowne Plaza CityCenter Azrieli, Tel-Aviv 08:00-08:20 Coffee and Registration 08:20-08:30 Greetings 08:30-10:00 First Session: Diagnosis and Management of Infective Endocarditis Chairs: Yasmin Maor, Edith Wolfson Medical Center, Holon, Israel Ran Nir- Paz, Hadassah Medical Center, Jerusalem, Israel 08:30-08:50 Bartonella species, a common but often missed cause of blood-culture-negative endocarditis Michael Giladi, the Infectious Disease Unit, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 08:50-09:20 Imaging of Endocarditis and the Role of Imaging in Diagnostics Gilbert Habib, La Timone Hospital, Marseille, France 09:20-09:40 Timing of surgery for complicated infective endocarditis Jacob Strahilevitz, Hadassah Medical Center, Jerusalem, Israel 09:40-10:00 Effect of surgical treatment for infective endocarditis on in-hospital mortality rate: Hadassah experience Sarah Israel, Hadassah Medical Center, Jerusalem, Israel 10:00-10:30 Coffee break 10:30-12:30 Second Session: Procedural Considerations and Treatment of Endocarditis/CIED Infection Chairs: Mahmoud Suleiman, Rambam Health Care Campus, Haifa, Israel Leonid Sternik, Sheba Medical Center, Tel Hashomer, Israel 10:30-11:00 The role of the antibiotic envelope Mauro Biffi, S.Orsola Malpighi Hospital, Bologna, Italy 11:00-11:30 Management of Embolic Events in Endocarditis Gilbert Habib, La Timone Hospital, Marseille, France 11:30-11:45 A 100 year old frail lady with infected pocket (Case Study) Are there alternatives to CIED system removal when risk is prohibitive? Michael Glikson, Shaare Zedek Medical Center, Jerusalem, Israel 11:45-12:00 LVAD Infections (including 1-2 Case Studies) Avi Morgan, Sheba Medical Center, Tel Hashomer, Israel 12:00-12:30 TAVR Infections (including 1-2 Case Studies) Gilbert Habib, La Timone Hospital, Marseille, France 12:30-14:00 Lunch 14:00-16:00 Third Session: Procedural Outcomes Chairs: Yoav Michovitz, Shaare Zedek Medical Center, Jerusalem, Israel Georgios Georghiou, President WG of Cardiac Surgery, Cyprus Society of Cardiology 14:00-14:30 What device should I re-implant after an extraction procedure? TBA 14:30-14:50 Is Mitral Valve Repair a Valid Option for MV Endocarditis? Hillit Cohen, Sheba Medical Center, Tel Hashomer, Israel 14:50-15:20 Is CIED Extraction a safe procedure? Mauro Biffi, S.Orsola Malpighi Hospital, Bologna, Italy 15:20-15:30 The dilemma of incomplete lead removal (Case Study) Eyal Nof, Sheba Medical Center, Tel Hashomer, Israel 15:30-16:00 The role of sub cutaneous ICD in prevention of endovascular infection Stefano Viani, Azienda Ospedaliero Universitaria Pisana, Toscana, Italy Organizing committee: Georgios P. Georghiou, MD President WG of Cardiac Surgery, Cyprus Society of Cardiology Michael Glikson Director of Jesselson Integrated Heart Center, Past president of the Israel Heart Society Councillor, Shaare Zedek Medical Center Ran Nir-Paz Associate Professor of Medicine, Department of Clinical Microbiology and Infectious Diseases, Hadassah- Hebrew University medical Center Eyal Nof Director of Invasive Electrophysiology Service, Davidai Arrhythmia Center, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel Ehud Raanani Cardiac Surgery, Director of the Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Israel, Chairman, Israel Society for Cardiothoracic Surgery, Professor of Surgery, Tel-Aviv University Jacob Strahilevitz Dept. of Clinical Microbiology & Infectious Diseases, Hadassah-Hebrew University Hospital, Jerusalem Miriam Weinberger Chair, the Israeli Society for Infectious Diseases Head, Infectious Diseases Unit, Shamir (Assaf Harofeh) Medical Center, Zerfin, Israel Sponsored by: .
Load more

Recommended publications
  • Therapeutic Hypothermia for Comatose Patients: VF Versus Other Initial Rhythm – Does It Matter?
    P13 - Posters - Intensive Cardiac Care Therapeutic Hypothermia for Comatose Patients: VF Versus Other Initial Rhythm – does it Matter? Avishag Laish-Farkash, Shlomi Matetzky, Samer Kassem, Alon Barsheshet, Hanny Haj-Iahia, Nataliya Ulanovsky, Hanoch Hod Heart Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 339 P13 - Posters - Intensive Cardiac Care The Value of Troponin-I Curve after Primary PCI for ST Elevation Myocardial Infarction Avishag Laish-Farkash 1,3, Hanoch Hod 1,3,Ben-Ami Sela2,3,Yoram Amsalem1,3, Athanasios Michailidis 1, Shlomi Matetzky 1,3 1 Heart Institute, 2 Institute for Chemical Pathology, Sheba Medical Center, Tel Hashomer, 3 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 340 P13 - Posters - Intensive Cardiac Care C-Reactive Protein as a Predictor of Active Coronary Disease and Worse Prognosis in Chest Pain Unit Dan Oieru 1,Roy Beigel1, Hanoch Hod 1,2, Pierre Chouraqui 1,2,Orly Goitein1, Eli Konen 1, Roy Beinart 1,Paul Fefer1,Ben-Ami Sela3,Ari Shamiss4,Jacob Or5, Shlomi Matetzky 1,2 1 Heart Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, 2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 3 Biochemical Laboratory, 4 Hospital Director, 5 Emergency Department, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 341 P13 - Posters - Intensive
    [Show full text]
  • Antibiotic Treatment for Invasive Listeriosis and Patient
    Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality.
    [Show full text]
  • Mortality of Patients with Rheumatoid Arthritis Requiring Intensive Care: a Single-Center Retrospective Study
    Clinical Rheumatology (2019) 38:3015–3023 https://doi.org/10.1007/s10067-019-04651-w ORIGINAL ARTICLE Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study Yael Haviv-Yadid1 & Yulia Segal2 & Amir Dagan3,4,5 & Kassem Sharif6 & Nicola Luigi Bragazzi7 & Abdulla Watad6 & Howard Amital6,8,9 & Yehuda Shoenfeld8,9,10,11 & Ora Shovman6,8,9 Received: 20 February 2019 /Revised: 10 June 2019 /Accepted: 18 June 2019 /Published online: 26 June 2019 # International League of Associations for Rheumatology (ILAR) 2019 Abstract Background Patients with rheumatoid arthritis (RA) are at a high risk for life-threatening conditions requiring admission to the intensive care unit (ICU), but the data regarding the outcomes of these patients is limited. The present study investigated the clinical characteristics and outcomes of RA patients admitted to an ICU. Methods This retrospective cohort study included RA patients admitted to the general ICU of the Sheba Medical Center during 2002–2018. The main outcome was 30-day mortality. Using Student’s t test, χ2, and multivariable analyses, we compared the demographic, clinical, and laboratory parameters of the survivors and the non-survivors. Figures with p value < 0.05 were considered statistically significant. Results Forty-three RA patients were admitted to the ICU during the study period (mean age, 64.0 ± 13.1 years; 74.4% female). The leading causes of ICU admission were infection (72.1%), respiratory failure (72.1%), renal failure (60.5%), and septic shock (55.8%). The 30-day mortality rate was 34.9%, with infection (9/15, 60%) as the most frequent cause.
    [Show full text]
  • December 2013 Prof. Reuven Zimlichman Chief of Medicine and Hypertension Institute, the E
    R. Zimlichman M.D. December 2013 Prof. Reuven Zimlichman Chief of Medicine and Hypertension Institute, The E. Wolfson Medical Center P.O.B. 5, Holon 58100 Israel and Head of Cardiovascular Research Institute, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel Phone: 972-3-5028614, FAX: 972-3- 5032693 e-mail: [email protected] Prof. R. Zimlichman, M.D. is presently Chief Departments of Medicine and Head of Hypertension Institute at the E. Wolfson Medical Center, Israel, he is the Director of The Brunner Cardiovascular Research Institute, Tel-Aviv University. He is also the immediate past Vice Dean and Head of School of Continuing Education, Sackler Faculty of Medicine, Tel Aviv University. Prof. Zimlichman did his fellowship in Hypertension at the Hypertension Endocrine Branch, NIH, NHLBI in Bethesda, Maryland, USA (1983 to 1986). During the following years he returned for prolonged periods of research in the Hypertension Endocrine Branch and in the Clinical Neurocardiology section. Prof. Zimlichman joined the Faculty of Health Sciences at Ben Gurion University and Soroka Medical Center in Beer Sheva, Israel. He was nominated as Chief of Clinical and Experimental Hypertension in the Faculty of Medicine and in the Medical Center. Prof. Zimlichman was nominated as Chief of Medicine in the Sheba Medical Center, Tel Hashomer, in 1989 and was nominated as Associate Professor in Medicine at the Tel Aviv University, Sackler School of Medicine in 1994. In 1991 Prof Zimlichman was nominated as Chief of Department of Medicine in the Wolfson Medical Center, and in 1998 was nominated as Chief Departments of Medicine at the Wolfson Medical Center.
    [Show full text]
  • APF Newsletter, Winter 2006 – 2007
    Winter 2006-2007 APF A Newsletter of the From The President AmericanEmergency Physicians andFellowship Disaster Preparednessfor Medicine in Israel Course News in Israel From The President Israel in Crisis Mission August 2006 would like to share with our members and donors the important by Dr. Dan Moskowitz I APF activities of the past 6 months. his past August, I had the privilege of being invited to par- 1. APF ISRAEL CRISIS FUND REPORT After placing on our T ticipate in an Emergency APF Mission to Israel with APF website and sending a special crisis appeal from Dr. Danny Laor, Board members Drs. Mike Frogel, Paul Liebman and Charles the Deputy Minister for Emergency Preparedness, on the critical Kurtzer. Dr. Boaz Tadmor organized an incredible, whirlwind needs of the Northern hospitals, it was very gratifying indeed that over $100,000 tour for us, only two days after the cessation of hostilities in was received for our Crisis Fund. All of this will be distributed to hospitals such as Israel. We were provided with a unique glimpse of the Israeli Sieff Hospital in Safed, Poriya in Tiberias, Western Galilee Medical Center in Nahariya, and Rambam Medical Center in Haifa, with the hospital CEO’s given the healthcare system under stress, including face-to-face meet- discretion as to how best to utilize these funds to help their hospital in light of the ings with top healthcare officials, as well as visits to the trau- recent crisis. matized hospitals in northern Israel. Perhaps most importantly, we visited 2. MISSION TO ISRAEL Three APF Board members, Drs.
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 26, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PeterPen) ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-040210 Article Type: Protocol Date Submitted
    [Show full text]
  • The 49Th Conference of the Israeli Society of Nephrology and Hypertension April 25Th - 27Th, 2013 | Dan Caesarea Hotel Scienti C Programme
    The 49th Conference of the Israeli Society of Nephrology and Hypertension April 25th - 27th, 2013 | Dan Caesarea Hotel Scientic Programme Organizing Committee Dr. Eliezer Golan, President, ISNH. Meir Medical Center, Kfar Saba Dr. Talia Weinstein, Vice-President, ISNH. Sourasky Medical Center, Tel Aviv Scientic Committee Dr. Suheir Assady, Chairperson, Rambam Health Care Campus, Haifa Dr. Talia Weinstein, Sourasky Medical Center, Tel Aviv Dr. Sydney Benchetrit, Meir Medical Center, Kfar Saba The 49th Conference of the Israeli Society of Nephrology and Hypertension April 25th - 27th, 2013 | Dan Caesarea Hotel Scientic Programme Day 1 - Thursday, April 25th, 2013 12:30 - 13:30 Reception, Exhibition & Lunch 13:30 - 13:50 Session 1 13:30 - 13:40 Greetings & Opening Remarks Dr. Suheir Assady, Dr. Eliezer Golan 13:40 - 13:50 ISNH RENAL REGISTRY (IRR) - Annual Report Dr. Eliezer Golan 13:50 - 15:15 Session 2 Chairs: Dr. Gabriel Mordochovic, Dr. David Tovbin 13:50 - 14:50 Free Communications- Dialysis and Hypertension 13:50 PERCUTANEOUS RENAL REVASCULARIZATION: A LONG TERM FOLLOW- UP OF 155 PROCEDURES Daniel Kushnir1, Jeri Marcusohn1, Alon Antebi1, Rima Sukhotnik1, and Victor Frajewicki1. 1 Department of Nephrology and Hypertension, Carmel Medical Center, Haifa. 14:00 PAIN MANAGEMENT IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: RESULTS OF ONE CENTER EXPERIENCE Isabelle Haggiag1,2, Yael Einbinder1, Jacques Bernheim 1,2 and Sydney Benchetrit1,2. 1 Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv. 14:10 RISK MANAGEMENT AND QUALITY CONTROL PARAMETERS IN ONE HEMODIALYSIS CENTER: A CLINICAL AND PATIENT CARE ATTITUDE Ze'ev Katzir1, Olga Shmain-Naidanov2, Relu Cernas1, Zvi Barnea1, Alexander Biro1, and Mona Boaz3.
    [Show full text]
  • Neuro-Ophthalmology in Israel
    Worldwide Neuro-Opthalmology Section Editor: Kathleen B. Digre, MD Neuro-Ophthalmology in Israel Ruth Huna-Baron, MD, Eitan Zvi Rath, MD FIG. 1. Pioneers of neuro-ophthalmology in Israel. euro-ophthalmology was introduced in Israel during challenge of the rapid development of new and expensive N the late 1970s by Riri Manor, Yochanan Goldhammer, diagnostic and therapeutic modalities, a committee of the and Isaac Gutman (Fig. 1). They trained with from William Ministry of Health each year announces new technologies Hoyt, Lawton Smith, and Myles Behrens, respectively. These and therapies to be included in basic health coverage. There pioneers trained many local ophthalmologists, neurologists, are 18 magnetic resonance imaging devices in Israel and 5 and neuro-ophthalmologists in Israel, and their efforts resulted interventional neurovascular units, and most medical in 21 neuro-ophthalmologists currently serving a population centers in the country have a neuro-ophthalmology service of 8 million. Many Israeli neuro-ophthalmologists did fellow- (Table 1). Much like in the United States, referrals come ships in the United States with a variety of other mentors, from neurologists, ophthalmologists, neurosurgeons inter- including Ronald Burde, Joel Glaser and Norman Schatz, ventional neuroradiologists, and endocrinologists. Mark Kupersmith, Byron Lam, Neil Miller, Barry Scarf, In 1997, the Israeli Neuro-Ophthalmology Society was and Jonathan Trobe. founded by Ririo Manor as a subspecialty section of the In Israel, each citizen is entitled to health care services Israeli Ophthalmology Society. Two annual meetings are under the National Health Insurance Law. To meet the organized by the society, of which one hosts a leading TABLE 1.
    [Show full text]
  • Israeli Cardio-Oncology Society Virtual Meeting Preliminary Program
    January 13-14, 2021 | Virtual Conference TOWARDS A COMPREHENSIVE CARDIAC-CANCER CARE Take this unique opportunity to join the ISCO 2021 conference and to effectively reach hundreds of cardiologists, oncologists and hemato-oncologists. Join us and present your research and technology to this influential and knowledgeable audience, and to have full access to all networking benefits. Conference secretariat - Dirigo Events & Conferences 3 Menorat Hamaor st. Tel-Aviv, Israel For more information, please contact: Tel: 03-7775485 | Email: [email protected] Yael Ziv Project Manager – Industry Liaison, Dirigo | Mobile: +972-54-5599821 | Email: [email protected] ISRAELI CARDIO-ONCOLOGY SOCIETY VIRTUAL MEETING PRELIMINARY PROGRAM Platinum Sponsorship Gold Sponsorship Silver Sponsorship January 13, 2021 15:45-16:00 Opening Session 15:45-15:47 Zaza Iakobishvili, Founder and Chair of the Meeting, Cardiology 15:47-15:49 Dan Gilon, Chair of the Meeting, Cardiology 15:49-15:51 David Sarid, Chair of the Meeting, Oncology 15:51-15:53 Martin Ellis, Chair of the Meeting, Hematology 15:53-15:55 Alex Lyon, ESC Cardio-Oncology Council 15:55-15:57 Bonnie Ky, JACC Cardio-Oncology 16:00-17:00 Plenary Session Chairs: Giorgio Minnotti, Faculty of Medicine and Surgery, Campus Bio-Medico University of Rome, Italy Alexander Battler, Chairman, Advisory Council on Cardiovascular Disease Management and Prevention, Ministry of Health, Israel 16:00-16:20 How to establish Cardio-Oncology collaboration Susan F. Dent, Associate Director of Breast Cancer Clinical Research, Co-Director Duke Cardio-Oncology Program, Durham, NC, USA 16:20-16:40 Guidelines in Cardio-Oncology: Gaps and Opportunities José Luis Zamorano, University Hospital Ramon Y Cajal, Madrid, Spain 16:40-17:00 Panel discussion: Future of Cardio-Oncology Richard H.
    [Show full text]
  • Phrenic Nerve Paralysis After Pediatric Cardiac Surgery: Role of Diaphragmatic Plication
    S2 - Ami Cohen Award Competition and Pediatric Cardiac Surgery Phrenic Nerve Paralysis after Pediatric Cardiac Surgery: Role of Diaphragmatic Plication Michael Katz 1,Uriel Katz2, Sion Houri 3,Hagi Dekel1, Akiva Tamir 2, Alona Raucher Sternfeld 2, Ilan Cohen 3, Michaela Witzling 4, Eli Hauptman 1,Lior Sasson1 1 Cardiothoracic Surgery, 2 Heart Institute, Pediatric Cardiology Unit, 3 Pediatric ICU, 4 Radiology, E. Wolfson Medical Center affiliated with the Sackler School of Medicine, Tel Aviv University, Holon, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 11 S2 - Ami Cohen Award Competition and Pediatric Cardiac Surgery Ligation of Patent Ductus Arteriosus for Premature Infants in the Intensive Care Units in the North of Israel Victor Rubchevsky, Dan Aravot, Tammah Safadi Cardiothoracic Surgery, Carmel Hospital, Haifa, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 12 S3 - Acute Coronary Syndromes Impact of Red Blood Cell Transfusion on Clinical Outcomes in Patients with Acute Myocardial Infarction Doron Aronson, Miry Blich, Michael Kapeliovich, Rafael Beyar, Walter Markiewicz, Haim Hammerman Cardiology, Rambam Medical Center, Haifa, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 13 S3 - Acute Coronary Syndromes Is the Increased Use of Coronary Angiography in Acute Coronary Syndromes Accompanied by a Survival Benefit? David Harpaz 1,2, Yoseph Rozenman 1,2,3, Valentina Boyko 2, Solomon Behar 2,3, Shmuel Gottlieb 2,3 1 The Heart Institute Holon, E. Wolfson Medical Center, Holon, 2 The Neufeld
    [Show full text]
  • Curriculum Vitae Deeb Zabeeda, Md
    CURRICULUM VITAE DEEB ZABEEDA, M.D. I.D. No.054465919; Passport No. 6980824 PLACE OF WORK: The E. Wolfson Medical Center Anesthesia Department Holon, Israel Tel: (03) 502-8211 Fax: (03) 503-6408 HOME ADDRESS: Hanna Senesh Street 25 Lod, Israel 71203 Tel: (08) 925-4812 BIRTH DATE / PLACE: October 28, 1958 / Lod, Israel FAMILY: Married, 3 children LANGUAGES: Arabic, Hebrew, German, English EDUCATION: 1970-1974 Intermediate School, Lod, Israel 1974-1976 High School, Kfar Tira, Israel 1978-1985 University of Leipzig, School of Medicine, Germany LICENSURE: May 1985 Diploma of Medicine Sep 1985 Medical License - Germany No. 126/85 Nov 1986 Medical License - Israel No. 018591 Nov 1994 Specialty in Anesthesia - Israel No. 14187 CLINICAL TRAINING AND EXPERIENCE Sep 1984-May 1985 Clinical training for German Medical Licensure Oct 1985-Oct 1986 Clinical training for Israeli Medical Licensure Feb 1987-Mar 1990 Anesthesia Residency, E. Wolfson Medical Center Holon, Israel. Apr 1990-Sep 1990 Internal Medicine Rotation, E. Wolfson Medical Center, Holon, Israel. Oct 1990-Mar 1991 Intensive Care Rotation, E. Wolfson Medical Center, Holon, Israel. Apr 1991-Sep 1991 Basic Science Rotation, Infection and Intensive Care Units, E. Wolfson Medical Center, Holon, Israel. Oct 1991-Apr 1993 Cardiac Surgery Anesthesia Rotation, E. Wolfson Medical Center, Holon Israel. May 1993-Sep 1993 Anesthesia for Neurosurgery, Ichilov Medical Center, Tel Aviv, Israel. Jan 1996-Apr 1996 Anesthesia for Pediatric Cardiac Surgery, Schneider Children’s Hospital, Petah Tiqva, Israel. May 1997-July1997 Pediatric Anesthesia, Sick Children’s Hospital, Toronto, Canada. 1994-present Senior Staff Anesthesiologist, E. Wolfson Medical Center, Holon, Israel.
    [Show full text]
  • The 7Th Fetal Neurosonography Masterclass
    THE 7TH FETAL NEUROSONOGRAPHY MASTERCLASS UNDER THE AUSPICES OF: ISRAELI SOCIETY OF ULTRASOUND IN OBSTETRICS & GYNECOLOGY May 31- June2, 2020 Kfar HaMaccabiah Hotel, Ramat Gan, Israel Course Directors Prof. Gustavo Malinger Prof. Mauricio Herrera For demonstrations of interest and enquires contact: [email protected] Welcome letter Dear Friends: I have been looking forward to see you in Israel and to have the opportunity to pass on the knowledge we had accumulated in the field of Fetal Neurosonography during the last 30 years. For more than two decades I worked at the Edith Wolfson Medical Center, where an exceptionally talented group of people had the opportunity to meet and work together to create in 1994 what was probably the first multidisciplinary group in the field of Fetal Neurology. The initial group was composed of Prof. Tally Lerman-Sagie (Pediatric Neurology), Dr. Dorit Lev (Genetics) and myself. Dr. Liat Ben Sira (Pediatric Radiology-MRI) joined from Tel Aviv Medical Center and Dr. Deborah Kidron (Pathology) from Sapir Medical Center. During the years the Fetal Neurology Clinic at Wolfson became the leader in the field of fetal CNS care and research in Israel with more than 500 referrals/year and more than 50 publications and a book. Eight years ago I moved from Wolfson to Tel-Aviv Sourasky Medical Center; the hospital has over 12000 deliveries per year and with the OB-GYN US Unit team we have an increasingly number of suspected CNS pathologies for evaluation and have diagnosed, in this relatively short period, more than 1200 CNS pathological cases. We will count with the participation of other Israeli renowned Fetal Medicine specialists including Dr.
    [Show full text]